CYTOPOINT®: an injectable that puts long-lasting control of canine atopic dermatitis in your hands1
Repeat administration monthly as needed in the individual patient.
Indication: CYTOPOINT treats clinical manifestations of atopic dermatitis in dogs.
Reference: 1. CYTOPOINT Summary of Product Characteristics.
The material contained within this website is intended to be viewed by practising veterinary surgeons in the UK only. The drugs listed in this website may have different technical specifications approved in other countries.
All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
© 2017 Zoetis Services LLC. All rights reserved. MM-01580
CYTOPOINT is a lokivetmab. For the treatment of clinical manifectations of atopic dermatitis in dogs. POM-V
For further information please see the product’s SPC or contact Zoetis UK Limited, Walton Oaks, Dorking Road, Tadworth, Surrey KT20 7NS. www.zoetis.co.uk. Customer Support: 0845 300 8034. Use medicines responsibly (www.noah.co.uk/responsible).